You are about to leave a GSK website.

By clicking this link, you will be taken to a website that is indenpendent from GSK.

The site you are linking to is not controlled and ensorded by GSK and GSK is not responsible for its content.

GSKPro Egypt Homepage

Report adverse event

Menu

Close

Close

  • My Events
  • Communication preferences

Basket

User logged in

Get in touch

Contact us

  • Gsk.com
Change Country
  • Change country
  • Terms of use
  • Privacy Notice
  • Cookie policy

 

Healthcare professionals are asked to report any suspected adverse reactions to Egyptian Pharmacovigilance Centre (EPVC) [hotline 15301].
e-mail: pv.followup@edaegypt.gov.eg or Egyptian Drug Authority (EDA) website: https://www.edaegypt.gov.eg

Adverse events should be reported to GlaxoSmithKline on +202 2618 5150 or by email at ae.egypt@gsk.com.
For any medical information requests, please reach us at: mi.egypt@gsk.com.

Trademarks are owned by or licensed to the GSK group of companies.

©2025 GSK group of companies or its licensor.

GlaxoSmithKline, Boomerang Building. P.O Box: 41 Building no. 46, Block (J), Fifth District – New Cairo, Cairo – Egypt Tel: +202 26185000

Sorry, this site is not supported on Android v4.3 and below.

Please update your operating system or use a different device.